Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Rapaport

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Hospital & Community Psychiatry|October 1, 1994
National Depression Screening Day: the San Diego experienceM H Rapaport, M Suminski
Acta Psychiatrica Scandinavica|November 1, 1994
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesiaM H Rapaport, J B Lohr
Anxiety|January 1, 1994
Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobiaM H Rapaport, M B Stein
Journal of Affective Disorders|July 21, 1998
Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatmentM H Rapaport, L L Judd
The Journal of Clinical Psychiatry|January 1, 1997
Panic disorder in a managed care environmentM H Rapaport, J J Cantor
Anxiety|January 1, 1994
Serum cytokine and soluble interleukin-2 receptors in patients with panic disorderM H Rapaport, M B Stein
Biological Psychiatry|August 22, 2001
The effects of lithium on ex vivo cytokine productionM H Rapaport, H K Manji
CNS Spectrums|July 7, 2005
An abbreviated review of immune abnormalities in schizophreniaM H Rapaport, K K Delrahim
Aviation, Space, and Environmental Medicine|June 1, 1985
Transderm scopolamine efficacy related to time of application prior to the onset of motionG D Levy, M H Rapaport
Psychopharmacology Bulletin|June 26, 1998
The efficacy of new pharmacological treatments for panic disorder: evaluating the trialsM H Rapaport, J R Davidson
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Hospital & Community Psychiatry|October 1, 1994
National Depression Screening Day: the San Diego experienceM H Rapaport, M Suminski
Acta Psychiatrica Scandinavica|November 1, 1994
Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesiaM H Rapaport, J B Lohr
Anxiety|January 1, 1994
Serum interleukin-2 and soluble interleukin-2 receptor levels in generalized social phobiaM H Rapaport, M B Stein
Journal of Affective Disorders|July 21, 1998
Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatmentM H Rapaport, L L Judd
The Journal of Clinical Psychiatry|January 1, 1997
Panic disorder in a managed care environmentM H Rapaport, J J Cantor
Anxiety|January 1, 1994
Serum cytokine and soluble interleukin-2 receptors in patients with panic disorderM H Rapaport, M B Stein
Biological Psychiatry|August 22, 2001
The effects of lithium on ex vivo cytokine productionM H Rapaport, H K Manji
CNS Spectrums|July 7, 2005
An abbreviated review of immune abnormalities in schizophreniaM H Rapaport, K K Delrahim
Aviation, Space, and Environmental Medicine|June 1, 1985
Transderm scopolamine efficacy related to time of application prior to the onset of motionG D Levy, M H Rapaport
Psychopharmacology Bulletin|June 26, 1998
The efficacy of new pharmacological treatments for panic disorder: evaluating the trialsM H Rapaport, J R Davidson
Pageof 9